These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 33064276)

  • 1. Intracellular Pharmacokinetics of Pyrimidine Analogues used in Oncology and the Correlation with Drug Action.
    Derissen EJB; Beijnen JH
    Clin Pharmacokinet; 2020 Dec; 59(12):1521-1550. PubMed ID: 33064276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular pharmacokinetics of gemcitabine, its deaminated metabolite 2',2'-difluorodeoxyuridine and their nucleotides.
    Derissen EJB; Huitema ADR; Rosing H; Schellens JHM; Beijnen JH
    Br J Clin Pharmacol; 2018 Jun; 84(6):1279-1289. PubMed ID: 29451684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IMP-GMP specific cytosolic 5'-nucleotidase regulates nucleotide pool and prodrug metabolism.
    Cividini F; Filoni DN; Pesi R; Allegrini S; Camici M; Tozzi MG
    Biochim Biophys Acta; 2015 Jul; 1850(7):1354-61. PubMed ID: 25857773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical pharmacology of nucleoside analogues].
    Milano G; Chamorey AL; Thyss A
    Bull Cancer; 2002 Aug; 89 Spec No():S71-5. PubMed ID: 12449033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the intracellular pharmacokinetics of the 5-fluorouracil nucleotides during capecitabine treatment.
    Derissen EJ; Jacobs BA; Huitema AD; Rosing H; Schellens JH; Beijnen JH
    Br J Clin Pharmacol; 2016 May; 81(5):949-57. PubMed ID: 26718616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gemcitabine: from preclinic to clinic passing by pharmacokinetics].
    Lokiec F; Lansiaux A
    Bull Cancer; 2007; 94 Spec No Actualites():S85-9. PubMed ID: 17845976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small Molecular Gemcitabine Prodrugs for Cancer Therapy.
    Miao H; Chen X; Luan Y
    Curr Med Chem; 2020; 27(33):5562-5582. PubMed ID: 31419928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines.
    Gourdeau H; Clarke ML; Ouellet F; Mowles D; Selner M; Richard A; Lee N; Mackey JR; Young JD; Jolivet J; Lafrenière RG; Cass CE
    Cancer Res; 2001 Oct; 61(19):7217-24. PubMed ID: 11585758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis.
    Balzarini J; Cooney DA; Dalal M; Kang GJ; Cupp JE; DeClercq E; Broder S; Johns DG
    Mol Pharmacol; 1987 Dec; 32(6):798-806. PubMed ID: 2826994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine: preclinical pharmacology and mechanisms of action.
    Plunkett W; Huang P; Searcy CE; Gandhi V
    Semin Oncol; 1996 Oct; 23(5 Suppl 10):3-15. PubMed ID: 8893876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capecitabine in carcinoma of the pancreas.
    Smith DB; Neoptolemos JP
    Expert Opin Pharmacother; 2006 Aug; 7(12):1633-9. PubMed ID: 16872266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine.
    Heinemann V; Hertel LW; Grindey GB; Plunkett W
    Cancer Res; 1988 Jul; 48(14):4024-31. PubMed ID: 3383195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs.
    Immordino ML; Brusa P; Rocco F; Arpicco S; Ceruti M; Cattel L
    J Control Release; 2004 Dec; 100(3):331-46. PubMed ID: 15567500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of nucleoside analogues: focus on haematological malignancies.
    Johnson SA
    Clin Pharmacokinet; 2000 Jul; 39(1):5-26. PubMed ID: 10926348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of gemcitabine in tumor and non-tumor extracellular fluid of brain: an in vivo assessment in rats employing intracerebral microdialysis.
    Apparaju SK; Gudelsky GA; Desai PB
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):223-9. PubMed ID: 17443325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monophosphorylation by deoxycytidine kinase affects apparent cellular uptake of decitabine in HCT116 colon cancer cells.
    Ueda K; Masuda A; Fukuda M; Tanaka S; Hosokawa M; Iwakawa S
    Drug Metab Pharmacokinet; 2017 Dec; 32(6):301-310. PubMed ID: 29174536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I dose escalation and pharmacokinetic evaluation of two different schedules of LY2334737, an oral gemcitabine prodrug, in patients with advanced solid tumors.
    Faivre SJ; Olszanski AJ; Weigang-Köhler K; Riess H; Cohen RB; Wang X; Myrand SP; Wickremsinhe ER; Horn CL; Ouyang H; Callies S; Benhadji KA; Raymond E
    Invest New Drugs; 2015 Dec; 33(6):1206-16. PubMed ID: 26377590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does saturable formation of gemcitabine triphosphate occur in patients?
    Tham LS; Wang LZ; Soo RA; Lee HS; Lee SC; Goh BC; Holford NH
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):55-64. PubMed ID: 18305939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population Pharmacokinetics of Intracellular 5-Fluorouridine 5'-Triphosphate and its Relationship with Hand-and-Foot Syndrome in Patients Treated with Capecitabine.
    Janssen JM; Jacobs BAW; Roosendaal J; Derissen EJB; Marchetti S; Beijnen JH; Huitema ADR; Dorlo TPC
    AAPS J; 2021 Jan; 23(1):23. PubMed ID: 33417061
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.